Literature DB >> 8425393

A controlled study of alexithymia in eating disorders.

U Schmidt1, A Jiwany, J Treasure.   

Abstract

The aims of the study were (1) to establish whether alexithymia is present in patients with bulimia nervosa (BN), (2) to compare bulimic patients with restricting anorexics (AN/R), bulimic anorexics (AN/BN), and normal controls with regard to alexithymia, (3) to determine whether in BN patients alexithymia is a state or a trait, and (4) to see whether alexithymia predicts short-term treatment outcome in BN. Study 1 included 173 eating disorder patients (BN: n = 93, AN/R: n = 55, AN/BN: n = 25) who were compared with 95 controls on the Toronto Alexithymia Scale (TAS). Study 2 included 41 BN patients who were assessed prospectively with the TAS before and after a 10-week drug treatment. AN/R patients in study 1 had significantly higher alexithymia scores than BN patients. All three eating disorder groups had significantly higher alexithymia scores than controls. For BN patients in study 2, TAS scores before and after drug treatment were stable, despite significant symptomatic improvement. We conclude the following: (1) eating disorder patients are considerably more alexithymic than normal controls; and (2) in BN, alexithymia may be a trait, unaffected by clinical improvement unless psychological treatment, encouraging the expression of emotions is offered.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425393     DOI: 10.1016/0010-440x(93)90036-4

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  35 in total

1.  The relationship between alexithymia and maladaptive perfectionism in eating disorders: a mediation moderation analysis methodology.

Authors:  S Marsero; G M Ruggiero; S Scarone; S Bertelli; S Sassaroli
Journal:  Eat Weight Disord       Date:  2011-09       Impact factor: 4.652

2.  Do parental traumatic experiences have a role in the psychological functioning of early adolescents with binge eating disorder?

Authors:  Cerniglia Luca; Cimino Silvia; Ballarotto Giulia; Tambelli Renata
Journal:  Eat Weight Disord       Date:  2016-07-20       Impact factor: 4.652

3.  Posttraumatic Stress and Interpersonal Sensitivity: Alexithymia as Mediator and Emotional Expressivity as Moderator.

Authors:  Gulnara Kobylanovna Slanbekova; Man Cheung Chung; Baizhol Iskakovich Karipbaev; Raikhan Shaikhishevna Sabirova; Roza Togayevna Alimbayeva
Journal:  Psychiatr Q       Date:  2019-03

4.  Evaluation of alexithymia and depression in severe obese patients not affected by eating disorders.

Authors:  A Da Ros; P Vinai; N Gentile; G Forza; S Cardetti
Journal:  Eat Weight Disord       Date:  2011-03       Impact factor: 4.652

5.  Alexithymia in female patients with eating disorders.

Authors:  O Montebarocci; M Codispoti; P Surcinelli; E Franzoni; B Baldaro; N Rossi
Journal:  Eat Weight Disord       Date:  2006-03       Impact factor: 4.652

6.  Incidental learning of food and emotional words in women with anorexia nervosa.

Authors:  T Suslow; P Ohrmann; J Lalee-Mentzel; U S Donges; V Arolt; A Kersting
Journal:  Eat Weight Disord       Date:  2004-12       Impact factor: 4.652

7.  Anorexia nervosa: Recent research findings and implications for clinical practice.

Authors:  Maria Råstam
Journal:  Eur Child Adolesc Psychiatry       Date:  1994-07       Impact factor: 4.785

Review 8.  An interoceptive model of bulimia nervosa: A neurobiological systematic review.

Authors:  Megan Klabunde; Danielle Collado; Cara Bohon
Journal:  J Psychiatr Res       Date:  2017-06-19       Impact factor: 4.791

9.  Emotional aspects of anorexia nervosa: results of prospective naturalistic cognitive behavioral group therapy.

Authors:  Susanne Ohmann; Christian Popow; Marcus Wurzer; Andreas Karwautz; Petra Sackl-Pammer; Bibiana Schuch
Journal:  Neuropsychiatr       Date:  2013-06-18

Review 10.  The role of cognitive deficits in the development of eating disorders.

Authors:  Suji M Lena; Alexandra J Fiocco; JoAnna K Leyenaar
Journal:  Neuropsychol Rev       Date:  2004-06       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.